Dexcom marked a milestone Friday after it became the first company to get FDA pre-market approval for its mobile apps to support continuous glucose monitoring. It is part of a larger push to make it easier for care managers and loved ones to keep an eye on glucose levels to avoid complications, such as hyperglycemia, which can affect the 25.8 million people with diabetes in the U.S. and increase healthcare costs.
Unlike the Dexcom Share charging cradle that the FDA cleared in October last year, the apps for the Dexcom Share Direct Secondary Displays system allow a lot more flexibility to share data between two iOS network smartphones. The Dexcom receiver had to be docked so the person with the CGM device had...
Also read: Kick the Buddy on the App Store